Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 14.90
-0.35 (-2.30%)
At close: Dec 5, 2025
Acepodia Revenue
Acepodia had revenue of 185.00K TWD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 301.00K, down -98.22% year-over-year. In the year 2024, Acepodia had annual revenue of 427.00K, down -97.43%.
Revenue (ttm)
301.00K
Revenue Growth
-98.22%
P/S Ratio
28,784.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
| Dec 31, 2023 | 16.59M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |